Friday & Cox LLC Friday & Cox LLC
An Injury & Compensation Law Firm

Dangerous Drugs Archives

PA Jury Awards Millions for Drug Company's Failure to Warn

A Philadelphia jury has awarded a $2.5 million dollar verdict to a plaintiff who suffered gynecomastia after taking the drug Risperdal.  Currently there are numerous pending cases involving harmful side effects allegedly caused by Risperdal.  Dangerous drug cases often involve a failure to adequately warn users of harmful side effects.  A drug manufacturer is required to warn its users of potential risks involved in taking the drug.  A failure to warn when a dangerous side effect is known is a basis of many mass tort cases involving pharmaceuticals--including the Risperdal cases.

Inadequate Label Warnings Leads to Large Verdict

Recently, the Pennsylvania Superior Court upheld a $10 million dollar verdict against the makers of Children's Motrin for failure to adequately warn consumers of the risks of taking the drug.  The jury did not find that the product was negligently designed, the verdict goes directly to the warnings contained on the product's packinging and labeling namely not listing the symptoms of "skin reddening", "rash",  and "blisters".

FDA Overturns Safety Limits on Diabetes Drug Avandia

The FDA recently overturned safety limits that restricted the sale of the diabetes drug Avandia (rosiglitazone).  The drug, manufacturered by GlaxoSmithKline had been much debated over the past several years due research done in 2007, which suggested that use of the drug was linked to a higher risk of heart attack.  The FDA limited the sale of the drug in response to the research findings in 2010 that suggested it use might be dangerous.  Now the drug is being unrestricted meaning that those suffering from diabetes will not have to enroll in a special program to obtain the drug.  This recent action by the FDA is not without controversy however, since no new informaton concerning the drug has been made available since the original decision was made.  Additionally, the doctor at the head of the 2007 study, which resulted in the FDA's safety restrictions is questioning the motives of the FDA. 

  • Lexis Nexis Martindale-Hubbell Peer Review Rated
  • Super Lawyers

    Peter D. Friday was selected as a
    Super Lawyer 2007-2014

  • Million Dollar Advocates Forum
  • Philadelphia Top Attorneys

Email Us for a Free Consultation

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Email or Call For a Consultation • 866-462-9607